Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Chalcogen attached indirectly to the diazine ring by nonionic bonding

Subclass of:

544 - Organic compounds -- part of the class 532-570 series

544000000 - ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1)

544000000 - HETEROCYCLIC CARBON COMPOUNDS CONTAINING A HETERO RING HAVING CHALCOGEN (I.E., OXYGEN, SULFUR, SELENIUM, OR TELLURIUM) OR NITROGEN AS THE ONLY RING HETERO ATOMS (Class 540, subclass 1)

544001000 - Hetero ring is six-membered having two or more ring hetero atoms of which at least one is nitrogen (e.g., selenazines, etc.)

544224000 - The six-membered hetero ring consists of two nitrogens and four carbons (e.g., 1,2-diazines, etc.)

544242000 - 1,3-diazines

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
544335000 Chalcogen attached indirectly to the diazine ring by nonionic bonding 16
20090118507Method for Preparing (3-Chloro-4-Fluorophenyl)-(4-Fluoro-4--Piperidin-1-Yl)-Methanone and Novel Intermediate Pyrimidine Derivatives - The present invention concerns the method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone of formula (II) by condensation between 5-methyl-pyrimidin-2-methylamine of formula (I) and cyanohydrin of formula (III).05-07-2009
20100048900AGENT FOR TREATMENT OF VASCULAR LEAKS - The invention relates to an agent which contains ectoines for the prophylactic or therapeutic treatment of endothelial function disturbances, in particular the VLS.02-25-2010
20100121061COMPOUNDS CAPABLE OF ACTIVATING CHOLINERGIC RECEPTORS - The present invention generally relates to nicotinic compounds, in the form of aryl substituted olefinic compounds, as well as pro-drug, N-oxide, metabolite and pharmaceutically acceptable salt forms thereof. Methods of modulating neurotransmitter release via administration of the compounds, pro-drugs, N-oxides and/or pharmaceutically acceptable salts are also disclosed.05-13-2010
20100130743HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES - Novel benzenedicarboxamides of the formula (I) wherein X represents hydrogen, halogen atom, nitro, C05-27-2010
20100292474DI-ALKYL SUBSTITUTED IMIDAZOLINE DERIVATIVES - The present invention describes a granular fabric softening composition comprising a di-alkyl substituted imidazoline derivative according to the formula;11-18-2010
20110003992MONO AND BIS-ESTER DERIVATIVES OF PYRIDINIUM AND QUINOLINIUM COMPOUNDS AS ENVIRONMENTALLY FRIENDLY CORROSION INHIBITORS - A quaternary nitrogen-containing corrosion inhibitor of formula01-06-2011
20110275813Bicylic 1,3-diones and Their Use as Insecticides, Acaricides and/or Fungicides - The present invention relates to the use of compounds of Formula (I) wherein R11-10-2011
20120029194LIQUID CRYSTAL COMPOUND HAVING DIFLUOROPROPENYLENEOXY BONDING GROUP - The invention provides a liquid crystal compound having general physical properties necessary for the compound, namely stability to heat, light and so forth, a wide temperature range of a liquid crystal phase, a high clearing point, a good compatibility with other compounds, a large optical anisotropy and a large dielectric anisotropy; a compound represented by formula (1):02-02-2012
20120065397PREPARATION OF KETONE AMIDES - The present invention discloses a novel process to prepare ketone amides, which are useful intermediates for the preparation of antagonists of CCR5 receptor and therefore useful for the treatment of HIV virus infected mammals. It specifically discloses a novel process to synthesize 1-(2,4-dimethylpyrimidine-5-carbonyl)-4-piperidone, 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4-piperidone and related compounds. A salient feature of the invention is the use of a three-phase reaction medium with an organic phase and a buffer salt slurry.03-15-2012
20120214996COMPOUNDS USEFUL AGAINST KINETOPLASTIDEAE PARASITES - Dibenzylidene and heterobenzylideneacetone derivatives, related 4-piperidones, related 4-thiopyranones and the corresponding sulfinyl- and sulfonyl-analogues for their use for prophylaxis or treatment of trypanosomiasis and leishmaniasis.08-23-2012
20130172558NAPROXEN-BASED CHIRAL COMPOUNDS AND LIQUID CRYSTAL DISPLAY APPLICATIONS - Naproxen-based ferroelectric liquid crystal (FLC) or nematic liquid crystal chiral compounds, which can be used in liquid crystal compositions useful for electro-optical and display device applications. The liquid crystal can be a ferroelectric liquid crystal. Also provided is a display device that includes the Naproxen-based ferroelectric liquid crystal (FLC) or nematic liquid crystal chiral compound. Also provided is a method of preparing a liquid crystal display device on silicon that includes incorporating the Naproxen-based ferroelectric liquid crystal (FLC) or nematic liquid crystal chiral compound, into a liquid crystal display on silicon by disposing the compound in a liquid crystal, or the liquid crystal, onto a silicon surface.07-04-2013
20140121375METHOD FOR PREPARATION OF 5-SUBSTITUTED PYRIMIDINES - The present invention provides a method to prepare 5-substituted pyrimidines by reacting a 5-acylpyrimidine with a suitable nucleophile to afford a 5-methanolpyrimidine, such as flurprimidol.05-01-2014
20140364608ARYLOXYACETAMIDE COMPOUND AND PESTICIDE - The present invention provides a pesticide comprising an aryloxyacetamide compound represented by formula (IV) (wherein in formula (IV), R12-11-2014
20150087833ALKYL PHENYL SULFIDE DERIVATIVE AND PEST CONTROL AGENT - An alkyl phenyl sulfide derivative represented by the general formula [I] or an agriculturally acceptable salt thereof, and a pest control agent containing the derivative or the salt as an active ingredient.03-26-2015
20150329566CYCLOPROPYLBORONIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF - Cyclopropylboronic compounds, the preparation process thereof and the use thereof.11-19-2015
20160046592PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES - An object is to provide a novel compound which has a glycogen synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. Provided is a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof:02-18-2016

Patent applications in class Chalcogen attached indirectly to the diazine ring by nonionic bonding

Website © 2023 Advameg, Inc.